Our unique approach
The ultimate goal of Against Breast Cancer is to stop secondary breast cancer from claiming lives through prevention, earlier detection and more effective treatments.
Against Breast Cancer’s co-founder Dr. Anthony Leathem, discovered during his own research that secondary breast cancers had an unusual arrangement of sugars on the cancer cell surface. Today, Against Breast Cancer funds research into secondary breast cancer with a special interest in the sugar biology (glycobiology) involved. This sets us apart from other breast cancer charities.
Investing in new research
We fund research which addresses:
- How the body’s natural defences could be harnessed to design more effective treatments and ultimately a vaccine against breast cancer
- How to design better tools for earlier diagnosis of secondary breast cancer to increase survival rates
- How diet and lifestyle may increase or reduce the risk of secondary breast cancer developing to provide sound, evidence-based advice relevant to a UK population
Investing in education
Against Breast Cancer established a Fellowship Programme in 2014 to support and develop young scientists who perform innovative research into increasing survival rates after breast cancer diagnosis.
The first Fellowship has been awarded to Dr. Max Crispin of the Glycoprotein Therapeutics Laboratory at the University of Oxford, who is researching carbohydrate-based vaccines and therapeutic antibodies.
The Fellowship is associated with Oriel College, Oxford, which was founded in 1326. Dr. Crispin has developed new therapeutic approaches for the treatment of cancer based on refocusing of the immune system to destroy cancerous cells.
The Against Breast Cancer Fellowship will support continued innovation in breast cancer therapeutics to advance our knowledge of the interplay between antibodies and development of secondary cancers, or metastases, in breast cancer patients.
Building a Biobank
In response to a critical need for biological samples to study breast cancer, Against Breast Cancer established and funded the collection of much needed clinical material from over 3000 UK breast cancer patients in our DietCompLyf Study.
Driving knowledge exchange
Against Breast Cancer recognise the importance of bringing experts from industry and academia together to accelerate scientific discovery, and we are proud to sponsor the 1st Biochemical Society and Against Breast Cancer Glyco Oncology Workshop. This is being held on April 6th 2017 in Oxford University’s New College to advance research and develop novel diagnostic tools and treatments, particularly for metastatic cancer patients.
The workshop will consist of short (flash) presentations followed by round table discussions on ‘hot topics’, training sessions targeted to new technologies and ‘surgeries’ to link up established glycobiology experts with groups needing support and specific techniques. Registration opens in January 2017. Read more